Fungal biology and classification
- General mycology
What fungi are, the difference between yeasts and moulds, how they are grouped, and why their cell wall and membrane are the targets of antifungal drugs.
What it is
Fungi are eukaryotes with a rigid wall of chitin and glucans and a membrane sterol, ergosterol, that human cells lack. They grow as single budding cells (yeasts), as branching filaments (moulds) or switch between the two (dimorphic fungi). Medical mycology sorts infections by the depth of tissue involved and by whether the fungus is a true pathogen or an opportunist.
Key facts
- Dimorphic fungi grow as moulds in soil at room temperature and as yeasts (or spherules) in tissue at body temperature: Histoplasma, Blastomyces, Paracoccidioides, Sporothrix, Talaromyces; Coccidioides forms spherules
- Main groups: Ascomycota (Candida, Aspergillus, dermatophytes, dimorphic fungi, Pneumocystis), Basidiomycota (Cryptococcus, Malassezia) and Mucoromycota (Mucorales)
- Pneumocystis has little ergosterol, so azoles and polyenes do not work; it is treated with trimethoprim-sulfamethoxazole
- Only four antifungal classes treat systemic infection, and resistance is rising (Candida auris, azole-resistant Aspergillus fumigatus)
- Most people inhale fungal spores without disease; serious infection mainly affects people with weakened immunity, devices or hospital stays
Structure
- Cell wall: chitin, beta-1,3-glucan and mannoproteins; it has no human counterpart, so it is a drug and diagnostic target
- Cell membrane: contains ergosterol instead of cholesterol
- Yeasts: round or oval single cells that reproduce by budding; Candida also forms pseudohyphae and true hyphae (germ tubes)
- Moulds: tubular hyphae that form a mycelium; septate with acute-angle branching (Aspergillus) or wide, ribbon-like and nearly aseptate with right-angle branching (Mucorales)
- Spores: asexual conidia are light and airborne, so most systemic mycoses start by inhalation
- Capsule: Cryptococcus has a polysaccharide capsule that resists phagocytosis and is detected by antigen tests
Function
- Polyenes (amphotericin B, nystatin) bind ergosterol and open pores in the membrane
- Azoles (fluconazole, itraconazole, voriconazole, posaconazole) block ergosterol synthesis at lanosterol 14-alpha-demethylase
- Allylamines (terbinafine) block squalene epoxidase, earlier in ergosterol synthesis
- Echinocandins (caspofungin, micafungin) block beta-1,3-glucan synthase in the wall; no activity against Cryptococcus or Mucorales
- Flucytosine is converted inside the fungus to an antimetabolite that blocks nucleic acid synthesis
- Griseofulvin disrupts fungal microtubules and is concentrated in keratin
Mycoses by depth
| Level | Tissue | Typical agents | How it is acquired |
|---|---|---|---|
| Superficial | Outermost skin layer or hair shaft, no inflammation | Malassezia (pityriasis versicolor), Hortaea (tinea nigra), Piedraia | Skin colonisation |
| Cutaneous | Keratin of skin, hair and nails | Dermatophytes: Trichophyton, Microsporum, Epidermophyton; Candida | Contact with people, animals or soil |
| Subcutaneous | Dermis and subcutis, sometimes lymphatics | Sporothrix, chromoblastomycosis agents, eumycetoma agents | Traumatic implantation (thorns, splinters, cat scratch) |
| Endemic systemic | Lungs first, then dissemination | Histoplasma, Paracoccidioides, Coccidioides, Blastomyces, Talaromyces | Inhaling spores in endemic areas |
| Opportunistic | Any organ in immunosuppressed hosts | Candida, Aspergillus, Cryptococcus, Mucorales, Pneumocystis | Own flora or ubiquitous spores |
In the lab
- Direct examination: potassium hydroxide (KOH) or calcofluor white for hyphae and yeasts; India ink or capsular antigen for Cryptococcus
- Culture on Sabouraud agar; dimorphism confirmed by growth at two temperatures
- Biomarkers: galactomannan for Aspergillus; beta-D-glucan for many fungi but not Cryptococcus or Mucorales
Common traps
- Echinocandins cover all invasive fungi: Cryptococcus and Mucorales are not susceptible, so they are the wrong choice for cryptococcal meningitis or mucormycosis.
- Pneumocystis is treated with antifungals like other fungi: it has little ergosterol, so azoles and polyenes fail; trimethoprim-sulfamethoxazole is used.
- A dimorphic fungus grows as a mould in the patient's tissue: in tissue it is a yeast (or a spherule for Coccidioides); the mould form is in the environment and in culture at room temperature.
- Any hyphae seen in tissue mean Aspergillus: Aspergillus hyphae are narrow, septate and branch at acute angles; broad, nearly aseptate, right-angle hyphae point to Mucorales.
- A negative beta-D-glucan rules out invasive fungal infection: the test misses Cryptococcus and Mucorales.
Test yourself
Think of the answer, then tap the question to see it.
A farmer from rural Colombia has chronic mouth ulcers and lung infiltrates; tissue shows yeasts with many buds. Why is a yeast seen when the fungus lives in soil as a mould?
Paracoccidioides is dimorphic: it grows as a mould at environmental temperature and switches to a yeast at body temperature in tissue.
A patient with diabetic ketoacidosis has a black, necrotic palate; biopsy shows broad, ribbon-like hyphae branching at right angles. Which group is it, and which drug class will not work?
Mucorales (mucormycosis). Echinocandins have no activity against Mucorales, so they cannot be relied on.
Why can a drug that blocks beta-1,3-glucan synthase kill Candida without harming human cells?
Beta-1,3-glucan is part of the fungal cell wall, and human cells have no wall and no glucan synthase, so the drug has no human target.
A man with advanced HIV has headache and fever; CSF shows encapsulated yeasts. Why is the capsule central to the diagnosis?
Cryptococcus has a polysaccharide capsule that shows as a halo on India ink and is detected by the capsular antigen test; it also helps the yeast resist phagocytosis.
Why do most systemic mycoses start in the lungs?
Moulds release light asexual spores (conidia) into the air; they are inhaled, so the lung is the first organ infected before any spread.
Connections
Microorganisms16
Educational content on microorganisms; not a treatment guide and no substitute for a health professional's advice. No doses are given.
Sources: About Fungal Diseases (CDC, 2024); WHO releases first-ever list of health-threatening fungi (World Health Organization (WHO), 2022); Clinical Overview of Aspergillosis (CDC, 2024).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
